Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...
Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...
Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how ...
CPIC 2026 opens in Shanghai on July 22. [Photo provided to chinadaily.com.cn] Global pharmaceutical leaders convened in ...
Priyanka Aggarwal, India and South East Asia Leader, Healthcare Practice at Boston Consulting Group (BCG), said patent ...
New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care ...
India's NITI Aayog has unveiled a blueprint for a $691 billion bioeconomy by 2035, proposing a ₹50,000-crore growth fund, six ...
One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and ...
StabilLux Biosciences has expanded by opening a new microscopy and cell culture laboratory, as the firm gets ready launch its ...
Operating from Nova Southeastern University's Center for Collaborative Research, ZEO ScientifiX is expanding physician education, scientific collaboration, and regenerative biologic innovation as ...
The United States and China are engaged in a competition that will shape far more than the future of medicine.
The approvals, along with a record high of about US$110 billion in out-licensing deals over the period, fully demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results